6 Recruiting Locally Advanced Pancreatic Adenocarcinoma Phase 2 Clinical Trials
Active phase 2 studies for locally advanced pancreatic adenocarcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Locally Advanced Pancreatic Adenocarcinoma studiesPhase 2 Studies for Locally Advanced Pancreatic Adenocarcinoma
🔵 Active, Not Recruiting Phase2
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔